Insilico Medicine and Takeda announced a strategic collaboration to advance drug candidates.
4 reports, 2 independent
Updated Jul 5
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Insilico Medicine and Takeda announced a strategic collaboration to advance drug candidates.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Insilico Medicine
American biotechnology company
Nothing else this week.
-
Takeda
company in Rome, Italy
Nothing else this week.
Related events
- Takeda and Protagonist Therapeutics secured global co-development rights and received FDA approval for a drug treating rare blood cancer.
- Insilico Medicine and Hangzhou Tigermed Consulting Co., Ltd. announced a collaboration focused on R&D.
- Insilico Medicine and Harvard Medical School have begun a collaboration focused on AI-driven drug discovery.
- Insilico Medicine, a company, is based in Cambridge, Massachusetts.